Data since the early 1900s indicate that influenza might increase the risk for cardiovascular complications. Today, we know ...

The FDA has placed a hold on all clinical studies of vaccines for respiratory syncytial virus in infants due to safety concerns following a trial involving two mRNA-based vaccine candidates from ...

Early results from Blue Lake trial found the vaccine to be safe, tolerated and able to cut the chance of contracting the infection.

Blue Lake Biotechnology, Inc., a clinical-stage intranasal vaccine company developing parainfluenza virus 5 (PIV5)-vectored ...

CIDRAP: Recombinant Pertussis Vaccine May Protect Teens For At Least 5 Years Researchers report that immunity against pertussis (whooping cough) was sustained 5 years after receipt of a ...

The burden of respiratory syncytial virus in young children continues to be high in the United States, according to study findings.

Symptoms of respiratory syncytial virus, or RSV, may start off similar to a common cold, with sneezing and a runny nose. But ...

A briefing document from the Food and Drug Administration (FDA) says that enrollment for all clinical studies of vaccines for ...

Bengaluru doctors are warning residents about a surge in respiratory and gastrointestinal infections attributed to ...

Finding a cure for colds and the flu is tricky to say the least, but new science may help you prevent them or at least ...

COVID-19, influenza, and RSV vaccination coverage is low among nursing home residents early in the 2024 to 2025 season.

Several bills introduced recently to address drug shortages aren’t expected to advance in this lame-duck Congress. But ...